| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3903064 | Urology | 2009 | 6 Pages |
Abstract
The results of our study have shown that DNA ploidy can serve as a surrogate biomarker that has the potential to replace biopsy Gleason scores for organ- vs nonorgan-confined PCa prediction.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sumit Isharwal, M. Craig Miller, Jonathan I. Epstein, Leslie A. Mangold, Elizabeth Humphreys, Alan W. Partin, Robert W. Veltri,